248 related articles for article (PubMed ID: 24614224)
1. PET brain imaging of neuropeptide Y2 receptors using N-11C-methyl-JNJ-31020028 in pigs.
Winterdahl M; Audrain H; Landau AM; Smith DF; Bonaventure P; Shoblock JR; Carruthers N; Swanson D; Bender D
J Nucl Med; 2014 Apr; 55(4):635-9. PubMed ID: 24614224
[TBL] [Abstract][Full Text] [Related]
2. Radiosynthesis and in vivo evaluation of novel radioligands for PET imaging of cerebral 5-HT7 receptors.
Hansen HD; Herth MM; Ettrup A; Andersen VL; Lehel S; Dyssegaard A; Kristensen JL; Knudsen GM
J Nucl Med; 2014 Apr; 55(4):640-6. PubMed ID: 24566002
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptor.
Shoblock JR; Welty N; Nepomuceno D; Lord B; Aluisio L; Fraser I; Motley ST; Sutton SW; Morton K; Galici R; Atack JR; Dvorak L; Swanson DM; Carruthers NI; Dvorak C; Lovenberg TW; Bonaventure P
Psychopharmacology (Berl); 2010 Feb; 208(2):265-77. PubMed ID: 19953226
[TBL] [Abstract][Full Text] [Related]
4. Characterization of N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-[1-(2-cyclopentyl-ethyl)-piperidin-4yl]acrylamide (JNJ-5207787), a small molecule antagonist of the neuropeptide Y Y2 receptor.
Bonaventure P; Nepomuceno D; Mazur C; Lord B; Rudolph DA; Jablonowski JA; Carruthers NI; Lovenberg TW
J Pharmacol Exp Ther; 2004 Mar; 308(3):1130-7. PubMed ID: 14617685
[TBL] [Abstract][Full Text] [Related]
5. Detection of alpha2-adrenergic receptors in brain of living pig with 11C-yohimbine.
Jakobsen S; Pedersen K; Smith DF; Jensen SB; Munk OL; Cumming P
J Nucl Med; 2006 Dec; 47(12):2008-15. PubMed ID: 17138744
[TBL] [Abstract][Full Text] [Related]
6. [11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain.
Pierson ME; Andersson J; Nyberg S; McCarthy DJ; Finnema SJ; Varnäs K; Takano A; Karlsson P; Gulyás B; Medd AM; Lee CM; Powell ME; Heys JR; Potts W; Seneca N; Mrzljak L; Farde L; Halldin C
Neuroimage; 2008 Jul; 41(3):1075-85. PubMed ID: 18434202
[TBL] [Abstract][Full Text] [Related]
7. 11C-NS14492 as a novel PET radioligand for imaging cerebral alpha7 nicotinic acetylcholine receptors: in vivo evaluation and drug occupancy measurements.
Ettrup A; Mikkelsen JD; Lehel S; Madsen J; Nielsen EØ; Palner M; Timmermann DB; Peters D; Knudsen GM
J Nucl Med; 2011 Sep; 52(9):1449-56. PubMed ID: 21828113
[TBL] [Abstract][Full Text] [Related]
8. Novel
Li S; Cai Z; Zheng MQ; Holden D; Naganawa M; Lin SF; Ropchan J; Labaree D; Kapinos M; Lara-Jaime T; Navarro A; Huang Y
J Nucl Med; 2018 Jan; 59(1):140-146. PubMed ID: 28747521
[TBL] [Abstract][Full Text] [Related]
9. What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of 11C-JNJ-42491293, A Novel Radioligand for mGluR2.
Leurquin-Sterk G; Celen S; Van Laere K; Koole M; Bormans G; Langlois X; Van Hecken A; Te Riele P; Alcázar J; Verbruggen A; de Hoon J; Andrés JI; Schmidt ME
J Nucl Med; 2017 Jan; 58(1):110-116. PubMed ID: 27469358
[TBL] [Abstract][Full Text] [Related]
10. The novel, selective, brain-penetrant neuropeptide Y Y2 receptor antagonist, JNJ-31020028, tested in animal models of alcohol consumption, relapse, and anxiety.
Cippitelli A; Rezvani AH; Robinson JE; Eisenberg L; Levin ED; Bonaventure P; Motley ST; Lovenberg TW; Heilig M; Thorsell A
Alcohol; 2011 Sep; 45(6):567-76. PubMed ID: 21145691
[TBL] [Abstract][Full Text] [Related]
11. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
[TBL] [Abstract][Full Text] [Related]
12. 11C-GSK189254: a selective radioligand for in vivo central nervous system imaging of histamine H3 receptors by PET.
Plisson C; Gunn RN; Cunningham VJ; Bender D; Salinas CA; Medhurst AD; Roberts JC; Laruelle M; Gee AD
J Nucl Med; 2009 Dec; 50(12):2064-72. PubMed ID: 19910432
[TBL] [Abstract][Full Text] [Related]
13. First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors.
Hillmer AT; Wooten DW; Bajwa AK; Higgins AT; Lao PJ; Betthauser TJ; Barnhart TE; Rowley HA; Stone CK; Johnson SC; Mukherjee J; Christian BT
J Nucl Med; 2014 Dec; 55(12):1973-9. PubMed ID: 25453045
[TBL] [Abstract][Full Text] [Related]
14. A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylamine ([11C]AFM).
Huang Y; Hwang DR; Bae SA; Sudo Y; Guo N; Zhu Z; Narendran R; Laruelle M
Nucl Med Biol; 2004 Jul; 31(5):543-56. PubMed ID: 15219271
[TBL] [Abstract][Full Text] [Related]
15. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
Sabri O; Becker GA; Meyer PM; Hesse S; Wilke S; Graef S; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Habermann B; Neuhaus P; Fischer S; Tiepolt S; Deuther-Conrad W; Barthel H; Schönknecht P; Brust P
Neuroimage; 2015 Sep; 118():199-208. PubMed ID: 26037057
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate.
Chattopadhyay S; Xue B; Collins D; Pichika R; Bagnera R; Leslie FM; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
J Nucl Med; 2005 Jan; 46(1):130-40. PubMed ID: 15632043
[TBL] [Abstract][Full Text] [Related]
17. N,N-dimethyl-2-(2-amino-4-(18)F-fluorophenylthio)-benzylamine (4-(18)F-ADAM): an improved PET radioligand for serotonin transporters.
Shiue GG; Choi SR; Fang P; Hou C; Acton PD; Cardi C; Saffer JR; Greenberg JH; Karp JS; Kung HF; Shiue CY
J Nucl Med; 2003 Dec; 44(12):1890-7. PubMed ID: 14660713
[TBL] [Abstract][Full Text] [Related]
18. Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Göttingen minipig: comparison with results in vivo.
Minuzzi L; Olsen AK; Bender D; Arnfred S; Grant R; Danielsen EH; Cumming P
Synapse; 2006 Mar; 59(4):211-9. PubMed ID: 16385509
[TBL] [Abstract][Full Text] [Related]
19. Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5.
Honer M; Stoffel A; Kessler LJ; Schubiger PA; Ametamey SM
Nucl Med Biol; 2007 Nov; 34(8):973-80. PubMed ID: 17998101
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 4 radiolabeled antagonists for serotonin 5-HT(7) receptor neuroimaging: toward the first PET radiotracer.
Lemoine L; Andries J; Le Bars D; Billard T; Zimmer L
J Nucl Med; 2011 Nov; 52(11):1811-8. PubMed ID: 21990574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
